Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001585904 | SCV001157101 | benign | not provided | 2019-07-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001585904 | SCV001811840 | likely benign | not provided | 2018-06-25 | criteria provided, single submitter | clinical testing | |
National Health Laboratory Service, |
RCV002225779 | SCV002505057 | benign | Hereditary breast ovarian cancer syndrome | 2022-04-19 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV001692339 | SCV002550881 | benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002290517 | SCV002582206 | likely benign | Hereditary cancer-predisposing syndrome | 2022-06-18 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002290516 | SCV002582769 | likely benign | Li-Fraumeni syndrome 1 | 2022-06-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002290517 | SCV002738777 | benign | Hereditary cancer-predisposing syndrome | 2014-11-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Clinical Genetics Laboratory, |
RCV001692339 | SCV001906434 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001692339 | SCV001972536 | benign | not specified | no assertion criteria provided | clinical testing |